Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NGM Biopharmaceuticals (NGM) News Today

NGM Biopharmaceuticals logo

NGM Latest News

Psychedelic Stock Deep Dive: Atai Life Sciences
Sino Biopharmaceutical Ltd 01177
Merck to buy eye drug developer for $1.3B
NGM Bio Announces Closing of Tender Offer
NGM Biopharmaceuticals (Nasdaq:NGM) Headline
Trading was temporarily halted for "NGM" at 07:04 PM with a stated reason of "News pending."...
NGM Bio To Be Acquired By Affiliates Of The Column Group, LP
NGM to go private through deal with investment firm
NGM Biopharmaceuticals (Nasdaq:NGM) Headline
Trading was temporarily halted for "NGM" at 08:02 AM with a stated reason of "News pending."...
NGM Biopharmaceuticals, Inc. (NGM)
Get NGM Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NGM and its competitors with MarketBeat's FREE daily newsletter.

NGM Media Mentions By Week

NGM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NGM
News Sentiment

0.00

0.56

Average
Medical
News Sentiment

NGM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NGM Articles
This Week

0

0

NGM Articles
Average Week

Get NGM Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NGM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NGM) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners